Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

4.05
Delayed Data
As of Aug 28
 +0.37 / +10.05%
Today’s Change
3.44
Today|||52-Week Range
11.74
-42.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization11.0K9.1K10.4K38.3K
 
 
 
 
 
 
Operating ExpensesGross Income-11.0K-9.1K-10.4K-38.3K
 
 
 
 
 
General Expenses12.4M8.6M11.6M22.2M
 
 
 
 
 
Research And Development9.5M5.5M6.9M14.9M
 
 
 
 
 
Total Operating Expenses12.4M8.6M11.6M22.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-12.4M-8.6M-11.6M-22.3M
 
 
 
 
 
Extraordinary Credit454.5K0.000.000.00
 
 
Extraordinary Charge0.00-91.6K-3.5M0.00
 
 
 
Interest Expense On Debt113.8K70.0K462.6K70.0K
 
 
 
 
 
Other Expenses-4.4K1.4K-120.6K-19.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.0M-8.7M-15.6M-22.3M
 
 
 
 
 
Net Income-12.0M-8.7M-4.6M-22.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.3M9.3M7.4M15.5M
 
 
 
 
 
Shares To Calculate EPS Diluted9.3M9.3M7.4M15.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$11.86-$0.94-$0.63-$1.44
 
 
 
 
 
EPS Diluted-$1.30-$0.95-$0.63-$1.44